Literature DB >> 28948260

Nonmetallic carbon monoxide releasing molecules (CORMs).

Nawodi Abeyrathna1, Kenyatta Washington, Christopher Bashur, Yi Liao.   

Abstract

Carbon monoxide (CO) is a gasotransmitter that plays important roles in regulating cell functions and has shown therapeutic effects in clinic studies. CO releasing molecules (CORMs), which allow controlled release of CO in physiological conditions, have been intensively studied in the past decade. While most CORMs are metal complexes, several nonmetallic CORMs have also been developed and most of them were reported in recent years. The major advantages of nonmetallic CORMs are potentially low toxicity and easy modification for property tuning. Syntheses, CO-release mechanisms, biological behaviors, and physicochemical properties of these nonmetallic CORMs are reviewed here. The first part of this short review covers the nonmetallic CORMs that do not require irradiation to release CO, which includes methylene chloride, CORM-A1 and its derivatives, amine carboxyboranes, and bimolecular CORMs. The second part focuses on the CORMs that release CO under irradiation (PhotoCORMs) including unsaturated cyclic diketones, xanthene carboxylic acids, meso-carboxy BODIPYs, and hydroxyflavones. Future prospects are discussed at the end of this review.

Entities:  

Year:  2017        PMID: 28948260     DOI: 10.1039/c7ob01674c

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  13 in total

1.  Visible-Light-Activated Quinolone Carbon-Monoxide-Releasing Molecule: Prodrug and Albumin-Assisted Delivery Enables Anticancer and Potent Anti-Inflammatory Effects.

Authors:  Marina Popova; Tatiana Soboleva; Suliman Ayad; Abby D Benninghoff; Lisa M Berreau
Journal:  J Am Chem Soc       Date:  2018-07-23       Impact factor: 15.419

2.  Metal Complexes for Therapeutic Applications.

Authors:  Johannes Karges; Ryjul W Stokes; Seth M Cohen
Journal:  Trends Chem       Date:  2021-04-14

3.  Flavonol-Based Carbon Monoxide Delivery Molecule with Endoplasmic Reticulum, Mitochondria, And Lysosome Localization.

Authors:  Livia S Lazarus; C Taylor Dederich; Stephen N Anderson; Abby D Benninghoff; Lisa M Berreau
Journal:  ACS Med Chem Lett       Date:  2022-02-01       Impact factor: 4.632

4.  Classification of Metal-based Drugs According to Their Mechanisms of Action.

Authors:  Eszter Boros; Paul J Dyson; Gilles Gasser
Journal:  Chem       Date:  2019-11-07       Impact factor: 22.804

5.  Towards "CO in a pill": Pharmacokinetic studies of carbon monoxide prodrugs in mice.

Authors:  Minjia Wang; Xiaoxiao Yang; Zhixiang Pan; Yingzhe Wang; Ladie Kimberly De La Cruz; Binghe Wang; Chalet Tan
Journal:  J Control Release       Date:  2020-08-01       Impact factor: 9.776

Review 6.  Carbon Monoxide and Nitric Oxide as Examples of the Youngest Class of Transmitters.

Authors:  Alicja Nowaczyk; Magdalena Kowalska; Jacek Nowaczyk; Grzegorz Grześk
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

7.  Activated charcoal dispersion of carbon monoxide prodrugs for oral delivery of CO in a pill.

Authors:  Xiaoxiao Yang; Wen Lu; Minjia Wang; Ladie Kimberly De La Cruz; Chalet Tan; Binghe Wang
Journal:  Int J Pharm       Date:  2022-03-08       Impact factor: 6.510

8.  Pharmacological Induction of Heme Oxygenase-1 Impairs Nuclear Accumulation of Herpes Simplex Virus Capsids upon Infection.

Authors:  Francisco J Ibáñez; Mónica A Farías; Angello Retamal-Díaz; Janyra A Espinoza; Alexis M Kalergis; Pablo A González
Journal:  Front Microbiol       Date:  2017-10-31       Impact factor: 5.640

Review 9.  Gas Signaling Molecules and Mitochondrial Potassium Channels.

Authors:  Agnieszka Walewska; Adam Szewczyk; Piotr Koprowski
Journal:  Int J Mol Sci       Date:  2018-10-18       Impact factor: 5.923

10.  Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia.

Authors:  John D Belcher; Edward Gomperts; Julia Nguyen; Chunsheng Chen; Fuad Abdulla; Zachary M Kiser; David Gallo; Howard Levy; Leo E Otterbein; Gregory M Vercellotti
Journal:  PLoS One       Date:  2018-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.